Hepion Pharmaceuticals (HEPA) Competitors $0.32 -0.02 (-6.09%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.31 -0.01 (-3.76%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HEPA vs. UPC, ADTX, HSTO, NAVB, VAXX, SMFL, SCPS, EVLO, CMRA, and GNCAQShould you be buying Hepion Pharmaceuticals stock or one of its competitors? The main competitors of Hepion Pharmaceuticals include Universe Pharmaceuticals (UPC), Aditxt (ADTX), Histogen (HSTO), Navidea Biopharmaceuticals (NAVB), Vaxxinity (VAXX), Smart for Life (SMFL), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), and Genocea Biosciences (GNCAQ). These companies are all part of the "pharmaceutical products" industry. Hepion Pharmaceuticals vs. Universe Pharmaceuticals Aditxt Histogen Navidea Biopharmaceuticals Vaxxinity Smart for Life Scopus BioPharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Universe Pharmaceuticals (NYSE:UPC) and Hepion Pharmaceuticals (NASDAQ:HEPA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment, community ranking and valuation. Do insiders & institutionals have more ownership in UPC or HEPA? 0.2% of Universe Pharmaceuticals shares are held by institutional investors. Comparatively, 17.2% of Hepion Pharmaceuticals shares are held by institutional investors. 57.4% of Universe Pharmaceuticals shares are held by company insiders. Comparatively, 4.7% of Hepion Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in UPC or HEPA? Hepion Pharmaceuticals received 21 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformUniverse PharmaceuticalsN/AN/AHepion PharmaceuticalsOutperform Votes2167.74% Underperform Votes1032.26% Which has more volatility & risk, UPC or HEPA? Universe Pharmaceuticals has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Comparatively, Hepion Pharmaceuticals has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Is UPC or HEPA more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A Hepion Pharmaceuticals N/A -812.56%-207.31% Does the media refer more to UPC or HEPA? In the previous week, Hepion Pharmaceuticals had 2 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 2 mentions for Hepion Pharmaceuticals and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.00 beat Hepion Pharmaceuticals' score of -0.13 indicating that Universe Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Universe Pharmaceuticals Neutral Hepion Pharmaceuticals Neutral Which has better earnings & valuation, UPC or HEPA? Universe Pharmaceuticals has higher revenue and earnings than Hepion Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$26.73M0.01-$6.16MN/AN/AHepion PharmaceuticalsN/AN/A-$48.93M-$219.000.00 SummaryUniverse Pharmaceuticals beats Hepion Pharmaceuticals on 6 of the 10 factors compared between the two stocks. Get Hepion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEPA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HEPA vs. The Competition Export to ExcelMetricHepion PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$45,000.00$6.45B$5.30B$7.35BDividend YieldN/A3.23%5.12%4.30%P/E Ratio-0.076.8921.8017.80Price / SalesN/A231.03379.9697.74Price / CashN/A65.6738.2634.64Price / Book0.255.936.443.98Net Income-$48.93M$142.99M$3.21B$247.73M7 Day Performance-23.31%4.42%2.87%1.81%1 Month Performance-58.81%-12.73%-8.63%-6.98%1 Year Performance-99.69%-9.48%11.46%1.37% Hepion Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HEPAHepion Pharmaceuticals0.3192 of 5 stars$0.32-6.1%N/A-99.7%$45,000.00N/A-0.0720Short Interest ↑News CoverageGap DownUPCUniverse PharmaceuticalsN/A$3.35-4.8%N/A-99.7%$144,000.00$26.73M0.00220ADTXAditxt0.3243 of 5 stars$2.50-13.2%N/A-100.0%$142,000.00$133,985.000.0060Short Interest ↑High Trading VolumeHSTOHistogenN/A$0.03flatN/AN/A$124,000.00$19,000.00-0.0120NAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-98.6%$60,000.00$8,126.000.0010Analyst ForecastVAXXVaxxinityN/A$0.00-98.0%N/A-97.6%$25,000.00N/A0.0090Upcoming EarningsGap UpSMFLSmart for LifeN/A$0.00-27.8%N/A-100.0%$18,000.00$11.11M0.00110Gap DownSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-98.9%$9,000.00N/A0.00120Upcoming EarningsOptions VolumeNews CoverageCMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070 Related Companies and Tools Related Companies UPC Alternatives ADTX Alternatives HSTO Alternatives NAVB Alternatives VAXX Alternatives SMFL Alternatives SCPS Alternatives EVLO Alternatives CMRA Alternatives GNCAQ Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HEPA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HEPA Stock Free HEPA Stock Alerts